US 11202776
Treatment of gastroparesis with triazaspiro[4.5]decanone
granted A61KA61K31/435A61K31/438
Quick answer
US patent 11202776 (Treatment of gastroparesis with triazaspiro[4.5]decanone) held by Takeda Pharmaceutical Company Limited expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/454, A61P